Intra-Cellular Therapies Inc at Canaccord Genuity Growth Conference Transcript
Pleased to have Intra-Cellular Therapies here today with us. Chief Commercial Officer, Mark Neumann is here, as well as Juan Sanchez who knows everything about the company, he's here in the audience as well.
Intra-Cellular has had a really nice launch of CAPLYTA, first with schizophrenia, and then, a real driver of growth has been the bipolar-depression market. And you have a lot of cool stuff going on in terms of that -- extension of that product for a franchise or rounding out that franchise as well as a lot of other things in your pipeline that we don't talk about as much as often probably as we should. (technical difficulty) And we'll go straight into Q&A if you don't mind.
Questions & Answers
Yeah, sure. First of all, I'd like to thank you for the invitation. It a pleasure to be hear to share with the audience offered products that we have at ITCI. If I could just mention some disclaimer before I
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
